C V Prowse
Impact in
- Hematology top 1%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Biochemistry top 2%
- Blood transfusion and management
Papers in
- Hematology 42
- Hemophilia Treatment and Research 21
- Platelet Disorders and Treatments 20
- Blood Coagulation and Thrombosis Mechanisms 18
- Biochemistry 11
- Blood transfusion and management 11
- Co-authors
- J. DawesDuncan S. PepperIan MacGregorV. HornseyJ. D. CashM. P. EsnoufHagop BessosP.L. Yap
- Journals
- Vox Sanguinis (17 papers)Thrombosis and Haemostasis (16 papers)Thrombosis Research (11 papers)British Journal of Haematology (4 papers)Blood Coagulation & Fibrinolysis (3 papers)
- Partner nations
- United KingdomFranceNetherlands
In The Last Decade
C V Prowse
73 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 110
- Hematology 668
- Biochemistry 255
- Management of Technology and Innovation 167
- Internal Medicine 89
- Critical Care and Intensive Care Medicine 79
Countries citing papers authored by C V Prowse
This map shows the geographic impact of C V Prowse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C V Prowse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C V Prowse more than expected).
Fields of papers citing papers by C V Prowse
This network shows the impact of papers produced by C V Prowse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C V Prowse. The network helps show where C V Prowse may publish in the future.
Co-authors
The 25 scholars most cited alongside C V Prowse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 101 | |
| 2 | 2011 | 26 | |
| 3 | 2010 | 4 | |
| 4 | 2009 | 8 | |
| 5 | 2008 | 26 | |
| 6 | 1999 | 82 | |
| 7 | 1999 | 9 | |
| 8 | 1998 | 7 | |
| 9 | 1997 | 86 | |
| 10 | 1995 | 7 | |
| 11 | 1995 | 5 | |
| 12 | Plasma and recombinant blood products in medical therapy | 1992 | 4 |
| 13 | 1990 | 3 | |
| 14 | 1988 | 6 | |
| 15 | 1988 | 19 | |
| 16 | 1987 | 1 | |
| 17 | 1985 | 10 | |
| 18 | 1984 | 46 | |
| 19 | 1983 | 25 | |
| 20 | 1979 | 30 |
About C V Prowse
C V Prowse is a scholar working on Hematology, Biochemistry, Genetics, Management of Technology and Innovation and Cell Biology, having authored 73 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (21 papers), Platelet Disorders and Treatments (20 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Blood transfusion and management (11 papers), Blood properties and coagulation (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Blood donation and transfusion practices (9 papers). The work is most often cited by research in Hematology (668 citations), Biochemistry (255 citations), Management of Technology and Innovation (167 citations), Internal Medicine (89 citations) and Critical Care and Intensive Care Medicine (79 citations). C V Prowse has collaborated with scholars based in United Kingdom, France and Netherlands. Frequent co-authors include J. Dawes, Duncan S. Pepper, Ian MacGregor, V. Hornsey, J. D. Cash, M. P. Esnouf, Hagop Bessos, P.L. Yap, C. A. Ludlam and Henley C. Harrison. Their work appears in journals such as Vox Sanguinis, Thrombosis and Haemostasis, Thrombosis Research, British Journal of Haematology and Blood Coagulation & Fibrinolysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.